Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for APC Nonsense Mutations in FAP
NCT04454151Phase 4Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Aug 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in familial adenomatous polyposis (FAP), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
azithromycin
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT04454151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04454151.